FTDI
RDY icon

First Trust Direct Indexing’s Dr. Reddy's Laboratories RDY Stock Holding History

First Trust Direct Indexing’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-60,910
Closed -$968K – 706
2024
Q3 		$968K Buy
60,910
+3,890
+7% +$62.6K 0.05% 354
2024
Q2 		$869K Buy
57,020
+3,850
+7% +$55.2K 0.05% 345
2024
Q1 		$780K Buy
53,170
+1,255
+2% +$18.3K 0.06% 350
2023
Q4 		$722K Buy
51,915
+6,130
+13% +$82K 0.06% 342
2023
Q3 		$612K Buy
45,785
+4,570
+11% +$61.8K 0.07% 336
2023
Q2 		$520K Sell
41,215
-685
-2% -$8K 0.06% 402
2023
Q1 		$477K Buy
41,900
+5,845
+16% +$63.1K 0.06% 412
2022
Q4 		$373K Buy
36,055
+6,010
+20% +$64.8K 0.05% 452
2022
Q3 		$315K Buy
30,045
+2,855
+11% +$30.4K 0.05% 453
2022
Q2 		$301K Buy
27,190
+3,110
+13% +$33.8K 0.04% 469
2022
Q1 		$268K Buy
24,080
+1,720
+8% +$19.5K 0.03% 537
2021
Q4 		$293K Sell
22,360
-500
-2% -$6.3K 0.04% 498
2021
Q3 		$298K Sell
22,860
-4,285
-16% -$57.1K 0.04% 474
2021
Q2 		$399K Buy
+27,145
New +$380K 0.06% 384

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

First Trust Direct Indexing's RDY Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Dr. Reddy's Laboratories (RDY) in Q4 2024, closing a stake of 60,910 shares — an estimated $968K sold.

First Trust Direct Indexing first reported a position in RDY in Q2 2021 and held it in 14 quarters. The position peaked at $968K in Q3 2024. 248 funds tracked by Wall St. Rank hold RDY as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Dr. Reddy's Laboratories position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 60,910 Dr. Reddy's Laboratories shares in Q4 2024, an estimated $968K.
  • First Trust Direct Indexing first reported a position in Dr. Reddy's Laboratories in Q2 2021 and held it in 14 quarters.
  • First Trust Direct Indexing's Dr. Reddy's Laboratories position peaked at $968K in Q3 2024.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.